The effects of spironolactone on atrial remodeling in patients with preserved left ventricular function after an acute myocardial infarction: a randomized follow-up study

ObjectivesAtrial remodeling is an important part of cardiac remodeling after acute myocardial infarction (AMI). The aim of this study was to evaluate the effect of spironolactone on atria in patients with preserved left ventricular (LV) functions after AMI by using two-dimensional and tissue Doppler imaging techniques (TDI). MethodsThe study consisted of 110 patients with AMI, successfully revascularized with percutaneous coronary intervention, ejection fraction greater than or equal to 40%, and Killip class I–II. Patients were randomized into two groups: conventional therapy (n=55) and additional spironolactone of 25 mg/day with standard conventional therapy (n=55). Echocardiography was performed in the first 48–72 h of AMI and during 6 months of follow-up. Left atrial volume index and emptying fraction were obtained. The peak regional atrial contraction velocity, the time between the onset of p-wave on the monitor ECG and the onset, peak, and the end (TE) of the atrial contraction wave on the tissue Doppler technique curve were measured. ResultsThe left atrial volume index and left atrium (LA) dimensions did not significantly change in either group. In the spironolactone group, left atrial emptying fraction increased compared with both baseline value (from 53.0±0.16 to 57.0±0.13 P=0.011) and conventional therapy group (from 50.0±0.17 to 47.0±0.16, P=0.013). The atrial contraction velocity did not change but the LA–TE, interatrial septum–TE, and right atrium–TE were prolonged in the conventional therapy group. ConclusionAdditional spironolactone therapy provided a little benefit on LA remodeling and atrial electromechanic properties in patients with AMI and preserved LV functions.

[1]  Jeroen J. Bax,et al.  Predictive value of total atrial conduction time estimated with tissue Doppler imaging for the development of new-onset atrial fibrillation after acute myocardial infarction. , 2010, The American journal of cardiology.

[2]  F. Giallauria,et al.  Favourable effects of exercise-based Cardiac Rehabilitation after acute myocardial infarction on left atrial remodeling. , 2009, International journal of cardiology.

[3]  J. McMurray,et al.  Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect? , 2009, American heart journal.

[4]  B. Pitt,et al.  Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study , 2009, Circulation.

[5]  I. Uzunhasan,et al.  Effects of aldosterone blockade on left ventricular function and clinical status during acute myocardial infarction , 2009, Scandinavian journal of clinical and laboratory investigation.

[6]  H. Drexler,et al.  Potential novel pharmacological therapies for myocardial remodelling. , 2008, Cardiovascular research.

[7]  L. Bodanese,et al.  Left atrioventricular remodeling in the assessment of the left ventricle diastolic function in patients with heart failure: a review of the currently studied echocardiographic variables , 2008, Cardiovascular Ultrasound.

[8]  Attila Nemes,et al.  Assessment of left atrial volume and function by real-time three-dimensional echocardiography. , 2008, International journal of cardiology.

[9]  W. Han,et al.  Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs. , 2008, Chinese medical journal.

[10]  Ş. Arslan,et al.  Left Atrial Remodeling in Acute Anterior Myocardial Infarction , 2007, Echocardiography.

[11]  C. Bauters,et al.  Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). , 2006, The American journal of cardiology.

[12]  M. Yoon,et al.  Impact of myocardial perfusion on left atrial remodeling following primary angioplasty for acute myocardial infarction , 2006, Coronary artery disease.

[13]  James B Seward,et al.  Left atrial size: physiologic determinants and clinical applications. , 2006, Journal of the American College of Cardiology.

[14]  B. Hoit,et al.  Selective Aldosterone Blockade Suppresses Atrial Tachyarrhythmias in Heart Failure , 2006, Journal of cardiovascular electrophysiology.

[15]  B. Jugdutt Matrix metalloproteinases as markers of adverse remodeling after myocardial infarction. , 2006, Journal of cardiac failure.

[16]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  J. Sanderson,et al.  Tissue Doppler echocardiographic evidence of atrial mechanical dysfunction in coronary artery disease. , 2005, International journal of cardiology.

[18]  C. Vassanelli,et al.  Left atrium: no longer neglected. , 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.

[19]  E. Vicaut,et al.  Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. , 2005, European heart journal.

[20]  L. Brodin,et al.  Assessment of atrial regional and global electromechanical function by tissue velocity echocardiography: a feasibility study on healthy individuals , 2005, Cardiovascular ultrasound.

[21]  C. Tei,et al.  Left Ventricular Remodeling is Less While Left Atrial Remodeling is Greater in Inferior Compared to Anterior Myocardial Infarction : Importance of Ischemic Mitral Regurgitation , 2004 .

[22]  E. Schwammenthal,et al.  Long-term prognostic significance of left atrial volume in acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[23]  B. Pitt,et al.  Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[24]  D. Ross,et al.  Changes in regional left atrial function with aging: evaluation by Doppler tissue imaging. , 2003, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[25]  M. Horie,et al.  Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction , 2003, Circulation.

[26]  J. Seward,et al.  Left Atrial Volume: A Powerful Predictor of Survival After Acute Myocardial Infarction , 2003, Circulation.

[27]  C. Delcayre,et al.  Molecular mechanisms of myocardial remodeling. The role of aldosterone. , 2002, Journal of molecular and cellular cardiology.

[28]  A. Goette,et al.  Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. , 2002, Cardiovascular research.

[29]  Ruben Coronel,et al.  Activation Delay After Premature Stimulation in Chronically Diseased Human Myocardium Relates to the Architecture of Interstitial Fibrosis , 2001, Circulation.

[30]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[31]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[32]  J. Vanoverschelde,et al.  Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. , 1990, Journal of the American College of Cardiology.

[33]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[34]  M. Matsuzaki,et al.  Importance of Left Atrial Function in Patients with Myocardial Infarction , 1983, Circulation.

[35]  N. Schiller,et al.  Normal left atrial function determined by 2-dimensional echocardiography. , 1983, The American journal of cardiology.

[36]  M S Spach,et al.  The Functional Role of Structural Complexities in the Propagation of Depolarization in the Atrium of the Dog: Cardiac Conduction Disturbances Due to Discontinuities of Effective Axial Resistivity , 1982, Circulation research.

[37]  K. Rosen,et al.  Left atrial transport function in myocardial infarction. Importance of its booster pump function. , 1975, The American journal of medicine.

[38]  E. Donal,et al.  Quantitative regional analysis of left atrial function by Doppler tissue imaging-derived parameters discriminates patients with posterior and anterior myocardial infarction. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[39]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.